IL7R and neoplasm: These findings advance our basic understanding of antitumor memory in the context of checkpoint inhibition or surgical resection, and suggest a strategy of using high IL-7R expression to enrich for memory T cells with superior antitumor activity from the tumor-draining lymph node, which can be augmented by epigenetic therapies for adoptive cell transfer.